Evaluates processing and quality of cottage cheese spread enriched with herbal bioactives, highlighting optimal formulations.
This study evaluated the effects of alginate–pullulan-encapsulated herbal bioactives on the processing characteristics, quality, and refrigerated storage stability of cottage cheese spread. Capsules containing rosehip, echinacea, and levzeya extracts were incorporated at levels of 0–5%, and the resulting samples were assessed for physicochemical properties, bioactive composition, antioxidant activity, rheological behavior, capsule integrity, sensory acceptability, and safety. The formulation containing 3% capsules was selected as the formulation providing the best balance between enrichment and product quality. It contained 0.94 mg/100 g vitamin C, 6.75 mg/100 g polyphenols, and 4.50 mg/100 g flavonoids, with DPPH antioxidant activity of 6.0% and a mean sensory score of 4.69/5. Capsule levels of 4–5% further increased bioactive content but reduced sensory scores to 4.11 and 3.71 because of more visible inclusions and lower taste and consistency ratings. During 7 days of refrigerated storage, moisture content and water activity remained statistically stable, and lactic acid bacteria remained close to 7 log10 CFU/g. Meanwhile, pH decreased, whereas titratable acidity and syneresis increased, with sensory deterioration becoming more evident after day 3. By day 7, vitamin C, polyphenols, and antioxidant activity retained 92.6%, 95.6%, and 94.0% of their initial values, respectively. Pathogenic microorganisms were not detected, and the tested safety indicators remained within permissible limits. These results demonstrate that 3% capsule incorporation provides a suitable balance between bioactive enrichment, processability, sensory acceptability, and refrigerated quality retention.
No takes yet. Share an insight, caveat, or question.
Muratbayev et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: